260 related articles for article (PubMed ID: 21398323)
1. Unusual morphological features of uterine leiomyomas treated with progestogens.
Boyd C; McCluggage WG
J Clin Pathol; 2011 Jun; 64(6):485-9. PubMed ID: 21398323
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
[TBL] [Abstract][Full Text] [Related]
3. Pathologic considerations of uterine smooth muscle tumors.
Prayson RA; Hart WR
Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
[TBL] [Abstract][Full Text] [Related]
5. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
Bell SW; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
[TBL] [Abstract][Full Text] [Related]
6. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
7. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
[TBL] [Abstract][Full Text] [Related]
8. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
Shi YF; Xie X; Zhao CL
Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
[TBL] [Abstract][Full Text] [Related]
9. Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.
Prescrire Int; 2014 May; 23(149):130-5. PubMed ID: 24926520
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
11. [Morphometric and histological evaluation of uterine leiomyomas treated with GnRH agonists or progestational agents].
Resta L; Sanguedolce F; Orsini G; Laricchia L; Piscitelli D; Fiore MG
Pathologica; 2004 Apr; 96(2):35-41. PubMed ID: 15449444
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous leiomyoma with cytologic atypia, akin to uterine symplastic leiomyoma.
Matthews JH; Pichardo RO; Hitchcock MG; Leshin B
Dermatol Surg; 2004 Sep; 30(9):1249-51; discussion 1251. PubMed ID: 15355371
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of p16 in uterine leiomyomas with infarct-type necrosis: an analysis of 35 cases.
Ip PP; Lim D; Cheung ANY; Oliva E
Histopathology; 2017 Nov; 71(5):743-750. PubMed ID: 28609585
[TBL] [Abstract][Full Text] [Related]
14. Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model.
Zhu Y; Qiu XY; Wang L; Wu JH; Liu GM; He GL; Jiang XR; Sun ZY; Cao L
Acta Pharmacol Sin; 2007 May; 28(5):685-94. PubMed ID: 17439725
[TBL] [Abstract][Full Text] [Related]
15. Pathological characteristics and clinical outcome of uterine leiomyomas associated with pregnancy.
Muezzinoglu B; Corakci A
Pathol Res Pract; 2011 Nov; 207(11):691-4. PubMed ID: 21993296
[TBL] [Abstract][Full Text] [Related]
16. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K
Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234
[TBL] [Abstract][Full Text] [Related]
17. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.
Ip PP; Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):691-704. PubMed ID: 21865091
[TBL] [Abstract][Full Text] [Related]
18. Hemorrhagic cellular leiomyomas ("apoplectic leiomyoma") of the uterus associated with pregnancy and oral contraceptives.
Norris HJ; Hilliard GD; Irey NS
Int J Gynecol Pathol; 1988; 7(3):212-24. PubMed ID: 3182168
[TBL] [Abstract][Full Text] [Related]
19. Small atypical leiomyomas: report of two cases.
Scurry J; Kerdemelidis P; Fortune D
Pathology; 2001 Aug; 33(3):319-21. PubMed ID: 11523933
[TBL] [Abstract][Full Text] [Related]
20. Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma.
Shapiro A; Ferenczy A; Turcotte R; Bruchim I; Gotlieb WH
Gynecol Oncol; 2004 Sep; 94(3):818-20. PubMed ID: 15350379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
